Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL262280 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL134427 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL981208 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL133830 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL984577 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL983251 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL982046 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL352667 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL982846 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT | |
| SCHEMBL983447 | 1.00 | THRB (0.56) | THRBHTTMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4161596-A1 | NANOFIBROUS MATERIAL PARTICULARLY FOR TOPICAL USE IN THERAPIES | Univerzita Karlova (CZ) | 2023-04-12 | — | — | EP | claimed |
| US-11135237-B2 | Lipophosphonoxins of second generation, and their use | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2021-10-05 | — | — | US | claimed |
| US-20210220383-A1 | LIPOPHOSPHONOXINS OF SECOND GENERATION, AND THEIR USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2021-07-22 | — | — | US | claimed |
| EP-3448865-B1 | LIPOPHOSPHONOXINS OF SECOND GENERATION, AND THEIR USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2019-09-04 | — | — | EP | claimed |
| WO-2017186200-A1 | LIPOPHOSPHONOXINS OF SECOND GENERATION, AND THEIR USE | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2017-11-02 | — | — | WO | claimed |
| EP-2527351-B1 | Lipophosphonoxins, method of their preparation and use | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2013-12-11 | — | — | EP | claimed |
| WO-2012021472-A2 | COMPOSITIONS AND METHODS FOR SEALING THE SURFACE OF KERATINOUS SUBSTRATES | L'OREAL S. A. (FR) | 2012-02-16 | — | — | WO | claimed |
| US-20050076578-A1 | Tunable composition and method for chemical-mechanical planarization with aspartic acid/tolyltriazole | VERSUM MATERIALS US, LLC | 2005-04-14 | — | — | US | claimed |
| JP-3602057-B2 | — | — | 2004-12-15 | — | — | JP | claimed |
| JP-2002538287-A | — | — | 2002-11-12 | — | — | JP | claimed |
| EP-1124920-A1 | CYCLIC THIOUREA ADDITIVES FOR LUBRICANTS | UNIROYAL CHEMICAL COMPANY, Inc. (US) | 2001-08-22 | — | — | EP | claimed |
| WO-2000053703-A1 | CYCLIC THIOUREA ADDITIVES FOR LUBRICANTS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2000-09-14 | — | — | WO | claimed |
| EP-0316618-B1 | Multilayer flat light sensitive registration material | BASF AG (DE) | 1994-08-17 | — | — | EP | claimed |
| US-5275749-A | Lubricants with corrosion inhibitors | KING INDUSTRIES, INC. (US) | 1994-01-04 | — | — | US | claimed |
| US-4294620-A | Phthalocyanine formulations | BASF AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | claimed |
| CN-118302407-A | Carbonyl compound, method for producing isocyanate compound, and isocyanate composition | 旭化成株式会社 | 2024-07-05 | — | — | CN | disclosed |
| CN-118215651-A | Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition | 旭化成株式会社 | 2024-06-18 | — | — | CN | disclosed |
| US-4255203-A | COMPRISING AN ORGANIC PIGMENT AND AN ARYL BISUREA DERIVATIVE; PRINTING INKS; PAINTS; GLOSS; COLOR INTENSITY, AND FLUID FLOW | BASF AKTIENGESELLSCHAFT (DE) | 1981-03-10 | — | — | US | disclosed |
| EP-0014907-A1 | Pigment preparations and lakes or printing dyes containing them | BASF Aktiengesellschaft (DE) | 1980-09-03 | — | — | EP | disclosed |
| EP-0014962-A1 | Preparations of phthalocyanines and offset printing dyes containing them | BASF Aktiengesellschaft (DE) | 1980-09-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11135237-B2 | Lipophosphonoxins of second generation, and their use | PLA2G1B, PLA2G2E, PLA2G4C | THRB 2528/4885HTT 4124/4885MEN1 1905/4885 |
| US-20210220383-A1 | LIPOPHOSPHONOXINS OF SECOND GENERATION, AND THEIR USE | PLA2G1B, PLA2G2E, PLA2G4C | THRB 2528/4885HTT 4124/4885MEN1 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.